Skip to main content
argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
814.94
+20.34 (2.56%)
At close: Feb 12, 2026

argenx SE Revenue

In the year 2025, argenx SE had annual revenue of $4.25B with 88.95% growth. argenx SE had revenue of $1.32B in the quarter ending December 31, 2025, with 74.57% growth.

Revenue
4.25B
Revenue Growth
+88.95%
P/S Ratio
10.53
Revenue / Employee
2.66M
Employees
1,599
Market Cap
44.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.25B2.00B88.95%
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Northwest Biotherapeutics 937.00K
Silence Therapeutics 559.00K
Vaxart 148.20M
BioStem Technologies 292.21M
Nuo Therapeutics 2.61M
Arch Biopartners 115.29K
ZIVO Bioscience 209.03K
Revenue Rankings

argenx SE News

More News